Data from Phase II Trial of Nivolumab in Metastatic Rare Cancer with dMMR or MSI-H and Relation with Immune Phenotypic Analysis (the ROCK Trial)
Authors:
- Hitomi S. OkumaHOHitomi S. Okuma
- Keisuke WatanabeKWKeisuke Watanabe
- Kenji TsuchihashiKTKenji Tsuchihashi
- Ryunosuke MachidaRMRyunosuke Machida
- Ryo SadachiRSRyo Sadachi
- Akihiro HirakawaAHAkihiro Hirakawa
- Hiroshi AriyamaHAHiroshi Ariyama
- Masashi KanaiMKMasashi Kanai
- Masahisa KamikuraMKMasahisa Kamikura
- Kenta AnjoKAKenta Anjo
- Akari HiramitsuAHAkari Hiramitsu
- Shigeki SekineSSShigeki Sekine
Open Access
- 15 December 2023
- other
- Published by American Association for Cancer Research (AACR)